Hainan Shuangcheng Pharmaceuticals Co Ltd Class A 002693
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 29.93
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Hainan Shuangcheng Pharmaceuticals Co Ltd is engaged in the research, development, and sales of synthesized peptide drugs.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 474
- Website
- http://www.shuangchengmed.com
Comparables
Valuation
|
Metric
|
002693
|
603896
|
300142
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 17.79 | 59.29 |
Price/Book Value | 12.39 | 1.94 | 1.88 |
Price/Sales | 29.93 | 5.45 | 5.26 |
Price/Cash Flow | 914.07 | 11.54 | 16.40 |
Price/Earnings
002693
603896
300142
Financial Strength
|
Metric
|
002693
|
603896
|
300142
|
|---|---|---|---|
Quick Ratio | 0.56 | 3.21 | 2.51 |
Current Ratio | 1.08 | 3.70 | 2.94 |
Interest Coverage | −9.96 | 16.62 | 24.73 |
Quick Ratio
002693
603896
300142
Profitability
|
Metric
|
002693
|
603896
|
300142
|
|---|---|---|---|
Return on Assets (Normalized) | −4.80% | 7.55% | 1.93% |
Return on Equity (Normalized) | −8.30% | 11.00% | 3.16% |
Return on Invested Capital (Normalized) | −4.45% | 7.10% | 2.01% |
Return on Assets
002693
603896
300142
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Cnfqgrntvx | Qshs | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Xtggdtqfp | Xdnqnq | $77.4 Bil | |||
| Haleon PLC ADR
HLN
| Zlhrxhp | Bnlx | $47.3 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Pkqypwbp | Bhv | $19.0 Bil | |||
| Viatris Inc
VTRS
| Yyqpjmq | Mlxw | $13.9 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Ptppvpvg | Cqrf | $13.4 Bil | |||
| Catalent Inc
CTLT
| Fzmhhrsp | Wrgvygn | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Jqtfbtjg | Wvkyhc | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Vqnzvry | Dsz | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Yxvcpjslzd | Qtdyr | $2.5 Bil |
United States